Testing effectiveness (Phase 2)Study completedNCT05283135What this trial is testingHigh Dose Risankizumab for PsoriasisWho this might be right forPsoriasis Oregon Medical Research Center 20
Not applicableStudy completedNCT05388916What this trial is testingA Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in ChinaWho this might be right forModerate to Severe Chronic Plaque Psoriasis Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT00669916What this trial is testingA Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque PsoriasisWho this might be right forPlaque Psoriasis Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01001468What this trial is testingStudy to Assess VB-201 in Patients With PsoriasisWho this might be right forActive Plaque Psoriasis Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Large-scale testing (Phase 3)Study completedNCT03598790What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 1,353
Post-approval studies (Phase 4)Study completedNCT02749370What this trial is testingStudy to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With ApremilastWho this might be right forPlaque Psoriasis Amgen 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03997786What this trial is testingTildrakizumab in Pediatric Subjects With Chronic Plaque PsoriasisWho this might be right forModerate-to-severe Chronic Plaque Psoriasis Sun Pharmaceutical Industries Limited 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07432854What this trial is testingA Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Dermavon Holdings Limited 540
Testing effectiveness (Phase 2)Study completedNCT04102241What this trial is testingEfficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Tianjin Hemay Pharmaceutical Co., Ltd 216
Large-scale testing (Phase 3)Study completedNCT04175613What this trial is testingA Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT06643260What this trial is testingStudy in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and EfficacyWho this might be right forPlaque Psoriasis Can-Fite BioPharma 705
Large-scale testing (Phase 3)Ended earlyNCT01708590What this trial is testingEfficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis SubjectsWho this might be right forPsoriasis Bausch Health Americas, Inc. 661
Testing effectiveness (Phase 2)Looking for participantsNCT07489885What this trial is testingEvaluate D-2570 in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis InventisBio Co., Ltd 75
Testing effectiveness (Phase 2)Study completedNCT01154101What this trial is testingStudy of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type PsoriasisWho this might be right forPsoriasis Sirtris, a GSK Company 40
Post-approval studies (Phase 4)Study completedNCT02690701What this trial is testingStudy to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Novartis Pharmaceuticals 91
Not applicableUnknownNCT05144165What this trial is testingSystemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French GuidelinesWho this might be right forPsoriasisPsoriasis PalmarisPsoriasis Inverse+8 more Centre of Evidence of the French Society of Dermatology 30
Not applicableStudy completedNCT01076192What this trial is testingStudy of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)Who this might be right forModerate-to-severe Chronic Plaque Psoriasis AbbVie (prior sponsor, Abbott) 547
Large-scale testing (Phase 3)Study completedNCT05975268What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis Shanghai Junshi Bioscience Co., Ltd. 747
Large-scale testing (Phase 3)Study completedNCT02672852What this trial is testingBI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatmentWho this might be right forPsoriasis AbbVie 507
Large-scale testing (Phase 3)Study completedNCT04595409What this trial is testingStudy to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Bioeq GmbH 392